Patent Assignment
Reel/Frame 021856/0582
Change of Name
Recorded: 2008-11-19
Pages: 4
Assignor
BIOLEX, INC.
Executed: 2007-10-11
Assignee
BIOLEX THERAPEUTICS, INC.
158 CREDLE STREET, PITTSBORO, NORTH CAROLINA, 27312
Covered Properties
(2)
Glycan-Optimized Anti-CD20 Antibodies
Application:
12/115,133 →
Publication:
US 2009/0060921
Glycan-Optimized Anti-CD20 Antibodies
Application:
60/916,125 →
Related Assignments
(6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Nov 14, 2008
From: DICKEY, LYNN F.; COX, KEVIN M.; PEELE, CHARLES G.
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 021836/0826 →
Assignment of Assignor's Interest
Nov 14, 2008
From: WANG, MING-BO
To: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
Reel/Frame 021836/0868 →
Assignment of Assignor's Interest
Nov 14, 2008
From: COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION
To: BIOLEX, INC.
Reel/Frame 021836/0901 →
Security Agreement
Nov 9, 2010
From: BIOLEX THERAPEUTICS, INC.
To: MIDCAP FINANCIAL SBIC, LP
Reel/Frame 025333/0026 →
Release of Security Interest
May 21, 2012
From: MIDCAP FINANCIAL SBIC, LP
To: BIOLEX THERAPEUTICS, INC.
Reel/Frame 028276/0548 →
Assignment of Assignor's Interest
May 22, 2012
From: BIOLEX THERAPEUTICS, INC.
To: SYNTHON BIOPHARMACEUTICALS B.V.
Reel/Frame 028278/0729 →